tiprankstipranks
Trending News
More News >
Percheron Therapeutics (AU:PER)
ASX:PER
Australian Market

Percheron Therapeutics (PER) Technical Analysis

Compare
12 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Neutral
0Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Percheron Therapeutics’s (PER) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Percheron Therapeutics is a Sell.
Percheron Therapeutics’s (PER) 20-Day exponential moving average is 0.01, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) 50-Day exponential moving average is 0.03, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.

Percheron Therapeutics (PER) Pivot Points

Apr 10, 2025, 03:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
<0.01
0.01
0.01
0.01
0.01
0.01
Fibonacci
<0.01
<0.01
0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Percheron Therapeutics (PER) Moving Averages

Apr 10, 2025, 03:19 PM
Period
Simple
Exponential
MA5
0.01Sell
0.01Sell
MA10
0.01Sell
0.01Sell
MA20
0.01Sell
0.01Sell
MA50
0.03Sell
0.03Sell
MA100
0.06Sell
0.05Sell
MA200
0.07Sell
0.07Sell
Percheron Therapeutics’s (PER) 10-Day exponential moving average is 0.01, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) 100-Day exponential moving average is 0.05, while Percheron Therapeutics’s (PER) share price is <AU$0.1, making it a Sell.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 50-day simple moving average is 0.03, creating a Sell signal.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 100-day simple moving average is 0.06, creating a Sell signal.
Percheron Therapeutics’s (PER) stock price is <AU$0.1 and Percheron Therapeutics’s (PER) 200-day simple moving average is 0.07, creating a Sell signal.

Percheron Therapeutics (PER) Technical Indicators

Apr 10, 2025, 03:19 PM
Name
Value
Implied Action
RSI (14)
27.63
Buy
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
77.78
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
60.50
Sell
Williams %R
-33.33
Buy
CCI (14)
176.47
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
60.65
Neutral
ROC
0.00
Buy
Percheron Therapeutics’s (PER) Relative Strength Index (RSI) is 27.63, creating a Buy signal.
Percheron Therapeutics’s (PER) Trend Strength Indicator (ADX) is 60.50, creating a Sell signal.
Percheron Therapeutics’s (PER) Commodity Channel Index (CCI) is 176.47, creating a Sell signal.

FAQ

Is PER a Buy, Hold, or Sell?
Based on PER’s technical indicators, PER is a Strong Sell.
    What is PER’s RSI (14)?
    PER’s RSI (14) is 27.63, which suggests PER is a Buy.
      What is PER’s MACD?
      PER’s MACD is >-0.01, which suggests PER is a Sell.
        What is PER’s 5-day moving average?
        PER’s 5-day moving average is 0.01, which suggests PER is a Sell.
          What is PER’s 20-day moving average?
          PER 20-day moving average is 0.01, which suggests PER is a Sell.
            What is PER’s 50-day moving average?
            PER’s 50-day moving average is 0.03, which suggests PER is a Sell.
              What is PER’s 200-day moving average?
              PER’s 200-day moving average is 0.07, which suggests PER is a Sell.
                What is PER’s Williams % R (14)?
                PER’s Williams % R (14) is -33.33, which suggests PER is a Buy.
                  What is PER’s CCI (14)?
                  PER’s CCI (14) is 176.47, which suggests PER is a Sell.
                    What is the share price of Percheron Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis